The Impact of Treatment Duration on Relapse Rates and Health Care Costs Among Medicaid Patients With Opioid Dependence Treated With Buprenorphine/Naloxone

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictors of Relapse in Patients With Opioid Addiction During Buprenorphine–Naloxone Maintenance Treatment

Addiction & Addictive Disorders
2015English

Cost Burden Analysis of Relapse in Prescription Opioid Drug Dependent Patients Treated With Buprenorphine/Naloxone and Patients Without Pharmacological Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

The Impact of Buprenorphine/Naloxone Treatment on HIV Risk Behaviors Among HIV-infected, Opioid-Dependent Patients

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2014English

Estimation of the Effect of Buprenorphine/Naloxone Dosing in Medicaid Opioid-Dependent Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Relationship Between Buprenorphine Adherence and Relapse, Health Care Utilization and Costs in Privately and Publicly Insured Patients With Opioid Use Disorder

Substance Abuse and Rehabilitation
2018English

Retention on Buprenorphine Treatment Reduces Emergency Department Utilization, but Not Hospitalization, Among Treatment-Seeking Patients With Opioid Dependence

Journal of Substance Abuse Treatment
MedicineClinical PsychologyPsychiatryPsychiatric Mental HealthMental Health
2012English

Impact of Medication Adherence and Presence of Comorbid Depressive Disorder on Health Care Costs Among Texas Medicaid Patients With Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Impact of Bariatric Surgery on Health Care Utilization and Costs Among Patients With Diabetes

Medical Care
EnvironmentalPublic HealthOccupational Health
2012English

New Developments in the Management of Opioid Dependence: Focus on Sublingual Buprenorphine–naloxone

Substance Abuse and Rehabilitation
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy